These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 23053090)
1. The novel antimicrobial peptide PXL150 in the local treatment of skin and soft tissue infections. Myhrman E; Håkansson J; Lindgren K; Björn C; Sjöstrand V; Mahlapuu M Appl Microbiol Biotechnol; 2013 Apr; 97(7):3085-96. PubMed ID: 23053090 [TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety profile of the novel antimicrobial peptide PXL150 in a mouse model of infected burn wounds. Björn C; Noppa L; Näslund Salomonsson E; Johansson AL; Nilsson E; Mahlapuu M; Håkansson J Int J Antimicrob Agents; 2015 May; 45(5):519-24. PubMed ID: 25649371 [TBL] [Abstract][Full Text] [Related]
3. Anti-infective efficacy of the lactoferrin-derived antimicrobial peptide HLR1r. Björn C; Mahlapuu M; Mattsby-Baltzer I; Håkansson J Peptides; 2016 Jul; 81():21-8. PubMed ID: 27155369 [TBL] [Abstract][Full Text] [Related]
4. In vivo bioluminescence imaging to evaluate systemic and topical antibiotics against community-acquired methicillin-resistant Staphylococcus aureus-infected skin wounds in mice. Guo Y; Ramos RI; Cho JS; Donegan NP; Cheung AL; Miller LS Antimicrob Agents Chemother; 2013 Feb; 57(2):855-63. PubMed ID: 23208713 [TBL] [Abstract][Full Text] [Related]
5. Characterization of the Håkansson J; Ringstad L; Umerska A; Johansson J; Andersson T; Boge L; Rozenbaum RT; Sharma PK; Tollbäck P; Björn C; Saulnier P; Mahlapuu M Front Cell Infect Microbiol; 2019; 9():174. PubMed ID: 31192163 [TBL] [Abstract][Full Text] [Related]
6. Recombinant production of Trx-Ib-AMP4 and Trx-E50-52 antimicrobial peptides and antimicrobial synergistic assessment on the treatment of methicillin-resistant Staphylococcus aureus under in vitro and in vivo situations. Satei P; Ghaznavi-Rad E; Fahimirad S; Abtahi H Protein Expr Purif; 2021 Dec; 188():105949. PubMed ID: 34324967 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of the designer antimicrobial peptide SHAP1 in wound healing and wound infection. Kim DJ; Lee YW; Park MK; Shin JR; Lim KJ; Cho JH; Kim SC Amino Acids; 2014 Oct; 46(10):2333-43. PubMed ID: 24952727 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of the novel topical antimicrobial agent PXL150 in a mouse model of surgical site infections. Håkansson J; Björn C; Lindgren K; Sjöström E; Sjöstrand V; Mahlapuu M Antimicrob Agents Chemother; 2014 May; 58(5):2982-4. PubMed ID: 24590479 [TBL] [Abstract][Full Text] [Related]
9. Cubosomes for topical delivery of the antimicrobial peptide LL-37. Boge L; Hallstensson K; Ringstad L; Johansson J; Andersson T; Davoudi M; Larsson PT; Mahlapuu M; Håkansson J; Andersson M Eur J Pharm Biopharm; 2019 Jan; 134():60-67. PubMed ID: 30445164 [TBL] [Abstract][Full Text] [Related]
10. Methicillin-resistant S. aureus infections among patients in the emergency department. Moran GJ; Krishnadasan A; Gorwitz RJ; Fosheim GE; McDougal LK; Carey RB; Talan DA; N Engl J Med; 2006 Aug; 355(7):666-74. PubMed ID: 16914702 [TBL] [Abstract][Full Text] [Related]
11. A Designed Host Defense Peptide for the Topical Treatment of MRSA-Infected Diabetic Wounds. Vargas A; Garcia G; Rivara K; Woodburn K; Clemens LE; Simon SI Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768463 [TBL] [Abstract][Full Text] [Related]
12. Identification of new dermaseptins with self-assembly tendency: membrane disruption, biofilm eradication, and infected wound healing efficacy. Song X; Pan H; Wang H; Liao X; Sun D; Xu K; Chen T; Zhang X; Wu M; Wu D; Gao Y Acta Biomater; 2020 Jun; 109():208-219. PubMed ID: 32276085 [TBL] [Abstract][Full Text] [Related]
13. Drugs for MRSA skin and soft-tissue infections. Med Lett Drugs Ther; 2014 May; 56(1442):39-40. PubMed ID: 24818839 [No Abstract] [Full Text] [Related]
14. A Foundation Model Identifies Broad-Spectrum Antimicrobial Peptides against Drug-Resistant Bacterial Infection. Li T; Ren X; Luo X; Wang Z; Li Z; Luo X; Shen J; Li Y; Yuan D; Nussinov R; Zeng X; Shi J; Cheng F Nat Commun; 2024 Aug; 15(1):7538. PubMed ID: 39214978 [TBL] [Abstract][Full Text] [Related]
15. Chen J; Hao D; Mei K; Li X; Li T; Ma C; Xi X; Li L; Wang L; Zhou M; Chen T; Liu J; Wu Q Microbiol Spectr; 2021 Dec; 9(3):e0131821. PubMed ID: 34908502 [TBL] [Abstract][Full Text] [Related]
16. Staphylococcus Aureus: Methicillin Resistance and Small Colony Variants from Pyogenic Infections of Skin, Soft Tissue and Bone. Ansari S; Nepal HP; Gautam R; Shrestha S; Chhetri MR; Chapagain ML J Nepal Health Res Counc; 2015; 13(30):126-32. PubMed ID: 26744197 [TBL] [Abstract][Full Text] [Related]
17. Antimicrobial peptide Epinecidin-1 promotes complete skin regeneration of methicillin-resistant Staphylococcus aureus-infected burn wounds in a swine model. Huang HN; Pan CY; Wu HY; Chen JY Oncotarget; 2017 Mar; 8(13):21067-21080. PubMed ID: 28177877 [TBL] [Abstract][Full Text] [Related]
18. Causative agents and antimicrobial resistance patterns of human skin and soft tissue infections in Bagamoyo, Tanzania. Kazimoto T; Abdulla S; Bategereza L; Juma O; Mhimbira F; Weisser M; Utzinger J; von Müller L; Becker SL Acta Trop; 2018 Oct; 186():102-106. PubMed ID: 30006029 [TBL] [Abstract][Full Text] [Related]
19. Emerging drugs for complicated skin and skin-structure infections. Mendoza N; Tyring SK Expert Opin Emerg Drugs; 2010 Sep; 15(3):509-20. PubMed ID: 20557269 [TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo activities of antimicrobial peptides developed using an amino acid-based activity prediction method. Wu X; Wang Z; Li X; Fan Y; He G; Wan Y; Yu C; Tang J; Li M; Zhang X; Zhang H; Xiang R; Pan Y; Liu Y; Lu L; Yang L Antimicrob Agents Chemother; 2014 Sep; 58(9):5342-9. PubMed ID: 24982064 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]